Retatrutide
Retatrutide
Research Use Only and not for human consumption. Bionk Peptides delivers high-performance research compounds engineered with uncompromising attention to detail. Every vial is produced to exceed 99% purity and supplied in lyophilised powder form, preserving molecular integrity while ensuring optimal stability and precision in application. Bionk Peptides are commitment to elevated research performance.
Couldn't load pickup availability
Description
Retatrutide
Retatrutide (LY3437943) is an investigational synthetic peptide developed as a multi-agonist for metabolic research. It acts as a triple agonist at the GLP-1, GIP, and glucagon receptors, giving it a unique profile for regulating energy balance, glucose metabolism, and weight management in experimental models. Research has explored its potential roles in obesity, type 2 diabetes, lipid regulation, and metabolic health. Retatrutide is of interest in studies focused on multi-pathway approaches to metabolic disorders.
- Triple agonist targeting GLP-1, GIP, and glucagon receptors
- Studied for effects on weight regulation and energy balance
- Investigated in models of type 2 diabetes and glucose control
- Explored for roles in lipid metabolism and metabolic health
- Preserving muscle mass during significant fat reduction
